810132C

18:1-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810132C

• Synonym(s): 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• Empirical Formula (Hill Notation): C₃₈H₆₄N₅O₁₁P
• CAS Number: 106974-05-4
• Molecular Weight: 797.92
• UNSPSC Code: 12352211
• NACRES: NA.25

Properties

• Assay: >99% (TLC)
• form: liquid
• packaging: pkg of 1 × 1 mL (810132C-1mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 810132C
• concentration: 1 mg/mL (810132C-1mg)
• shipped in: dry ice
• storage temp.: −20°C

Description

General description

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 18:1-06:0 NBD PC is a fluorescent lipid analog/probe.

Application

18:1-06:0 NBD PC is suitable for use:

• as a component in preparing lipid solution for bilayer formation
• to use as a single donor in fluorescence resonance energy transfer (FRET) based assay
• to prepare phospholipid-coated beads

Biochem/physiol Actions

NBD‐PC can be used to probe the existence of (Rho‐labeled) protease‐activated receptor (PAR) pepducins in the outer and inner leaflets.

Packaging

5 mL Amber Glass Screw Cap Vial (810132C-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Safety Information

• Pictograms: GHS06,GHS08
• Signal Word: Danger
• Hazard Statements: H302,H315,H319,H331,H336,H351,H361d,H372
• Precautionary Statements: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Target Organs: Central nervous system
• WGK: WGK 3